The pharmaceutical industry like Insurance, software and customer service industries did not go all out for the outsourcing. It was broadly due to the concerns over protecting valuable (and vulnerable) intellectual property. But now, down economy, rising costs and wafer thin margins are making large and medium (and small too) sized pharmaceutical companies to look for outsourcing.
Pharmaceutical manufacturers are now withdrawing from manufacturing at an unprecedented rate, with four of the top 10 players announcing major new outsourcing programmes in 2007, says IMS in a new document which explores the implications of that trend.
"This shift towards outsourcing of manufacturing is likely to be followed by other functions within pharmaceutical companies, including some elements of R&D," commented Murray Aitken, senior vice president for IMS' Healthcare Insight group, at a press conference earlier this month.
Source
Don't have time to visit the blog often? Let me send you outsourcing news, views, career tips, analysis, joke, humor, even bitching of the outsourcing world as they are publsihed in BPOTiger. You may subscribe here.
Comment Preview